Showing results (191-200 of 3,849) with videos related to
Sort By:
Pageof 385
Cancer Cell|April 13, 2011
Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancerMarina Lesina, Magdalena U Kurkowski, Katharina Ludes, et al.Cancer Cell|April 13, 2011
Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3Olga A Guryanova, Qiulian Wu, Lin Cheng, et al.Cancer Cell|June 14, 2011
Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kγ, a single convergent point promoting tumor inflammation and progressionMichael C Schmid, Christie J Avraamides, Holly C Dippold, et al.Cancer Cell|July 12, 2011
Comprehensive identification of somatic mutations in chronic lymphocytic leukemiaP Leif Bergsagel, W Michael KuehlCancer Cell|July 12, 2011
miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasisAvital Gaziel-Sovran, Miguel F Segura, Raffaella Di Micco, et al.Cancer Cell|July 12, 2011
Targeting androgen receptor in estrogen receptor-negative breast cancerMin Ni, Yiwen Chen, Elgene Lim, et al.Cancer Cell|December 16, 2014
Paradox-breaking RAF inhibitors that also target SRC are effective in drug-resistant BRAF mutant melanomaMaria Romina Girotti, Filipa Lopes, Natasha Preece, et al.Cancer Cell|January 14, 2015
mTOR signaling in melanoma: oncogene-induced pseudo-senescence?George P Souroullas, Norman E SharplessCancer Cell|January 14, 2015
mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formationWilliam Damsky, Goran Micevic, Katrina Meeth, et al.Cancer Cell|January 26, 2016
Genomic Sequencing Identifies ELF3 as a Driver of Ampullary CarcinomaShinichi Yachida, Laura D Wood, Masami Suzuki, et al.Pageof 385